Feirza 1.5/30 Tm Kit
Product Images NDC 70700-309

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Feirza 1.5/30 Tm (NDC 70700-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure illustration showing Norethindrone Acetate (C22H28O3, M.W. 340.46) and Ethinyl Estradiol (C20H24O2, M.W. 296.40), the active ingredients in FEIRZA 1.5/30 TM tablets.*

FDA Label Image

Table Ii: Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral Contraceptive Use (Image 02)

A bar chart showing mortality rates by age group among ever-users and controls, separated by smokers and non-smokers. The x-axis indicates age groups (15-24, 25-34, 35-44, 45+), and the y-axis shows mortality rate (number of deaths per 100,000 woman-years). Bars illustrate higher mortality rates for ever-smokers, especially in the 45+ age group.*

FDA Label Image

Blister Image With Instructions (Image 03)

An instructional diagram for FEIRZA 1.5/30 TM kit, showing a weekly pill schedule with days Sunday through Saturday, divided into four weeks. It includes directions for starting on Sunday or day 1 of menstrual period, arrows indicating pill-taking order left to right, and notes on the product's active ingredients norethindrone acetate and ethinyl estradiol, along with ferrous fumarate tablets.*

FDA Label Image

Day Label Sticker (Image 04)

An instructional diagram for FEIRZA 1.5/30 TM illustrating how to align the day label strip with the first day of the user's menstrual period. It shows seven strips of day labels starting with different days of the week across two rows, and instructions below for placing the appropriate strip over the preprinted weekly days on the blister pack, noting a special instruction if the period starts on Sunday.*

FDA Label Image

Blister Image With Instructions (Image 05)

An instructional diagram for FEIRZA 1.5/30 TM Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets kit. It shows a weekly pill schedule with circles for each day of the week organized in four rows for weeks 1 to 4, with guidance to start on Sunday or the first day of the period and to take pills left to right each week. The product NDC 70700-309 is indicated, along with storage instructions at 20° to 25°C and a total of 28 tablets.*

FDA Label Image

Day Label Sticker (Image 06)

An instructional diagram showing day label strips for each day of the week arranged in rows. The instructions guide the user to pick the strip starting with the first day of their period and place it over the blister pack to align with the correct days, noting that if the period starts on a Sunday, this step can be skipped.*

FDA Label Image

3s Carton (Image 07)

FEIRZA 1.5/30 TM kit packaging label showing Norethindrone Acetate and Ethinyl Estradiol Tablets USP 1.5 mg/30 mcg combined with Ferrous Fumarate Tablets 75 mg. The label indicates three pouches, each containing one blister pack with 28 tablets. The labeler is Xiromed LLC, and the NDC is 70700-309. The packaging includes dosage strengths and usage warnings.*

FDA Label Image

Figure 1: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 08)

A forest plot chart depicting effect estimates from multiple studies comparing combined oral contraceptive (COC) use versus never use. It shows odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals for studies including NICHD Women's Care Study, French E3N cohort, Shanghai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Study, and Danish Sex Hormone Register Study. The x-axis shows the effect estimate scale from -1.5 to 1.0 with data points indicating effect sizes and confidence intervals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.